Sorlandet Hospital HF clinical trials
Sorlandet Hospital HF is the lead sponsor of 11 current clinical trials in our Norway register. 9 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Stroke, Acute Ischemic.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Sorlandet Hospital HF
11 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality
NCT04942041 · ClinicalTrials.gov ↗ · Stroke, Acute Ischemic
|
Observational | Recruiting | 2021-01 | Norway |
|
Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance
NCT06983639 · ClinicalTrials.gov ↗ · Colorectal Neoplasms
|
Not applicable | Recruiting | 2026-01 | Norway |
|
Group-based ACT for Psychological Distress of Young People
NCT07617467 · ClinicalTrials.gov ↗ · Depression - Major Depressive Disorder, Depression Anxiety Disorder, Anxiety
|
Not applicable | Recruiting | 2026-03 | Norway |
|
Non-invasive Diagnostics of Microbial Keratitis
NCT06364878 · ClinicalTrials.gov ↗ · Infectious Keratitis
|
Observational | Recruiting | 2023-08 | Norway |
|
Where Wild Things Grow: Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth
NCT07203469 · ClinicalTrials.gov ↗ · Neurodevelopmental Outcomes, ADHD - Attention Deficit Disorder With Hyperactivity, Autism
|
Not applicable | Recruiting | 2025-09 | Norway |
|
The Southern-Norway Post-Stroke Atrial Fibrillation Study
NCT07407790 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Atrial Fibrillation (Prevention of Stroke), Ischemic Stroke
|
Not applicable | Recruiting | 2026-01 | Norway |
|
Group vs. Individual Metacognitive Therapy for Generalized Anxiety Disorder
NCT07579897 · ClinicalTrials.gov ↗ · Generalized Anxiety Disorder
|
Not applicable | Recruiting | 2026-03 | Norway |
|
The Good Pain Consultation in Endometriosis.
NCT07205614 · ClinicalTrials.gov ↗ · Pelvic Pain Syndrome, Endometriosis, Dysmenorrhea
|
Not applicable | Recruiting | 2025-11 | Norway |
|
Psychoeducation of Parents to Children With FASD
NCT05686473 · ClinicalTrials.gov ↗ · Fetal Alcohol Spectrum Disorders, Behavior Problem, Adaptive Behavior
|
Not applicable | Recruiting | 2025-05 | Norway |
|
REACT MCI - Repeated Advanced Cognitive Training in Mild Cognitive Impairment
NCT04792528 · ClinicalTrials.gov ↗ · Mild Cognitive Impairment
|
Not applicable | Active, closed | 2021-05 | Norway |
|
Surgical Approach in Hemiarthroplasty. A Randomized Clinical Trial Comparing Posterior and Anterior Approach
NCT04900506 · ClinicalTrials.gov ↗ · Femoral Neck Fractures, Bone Mineral Density, Muscle Damage
|
Not applicable | Active, closed | 2022-01 | Norway |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in Sorlandet Hospital HF trials
29 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Norway | 11 | 9 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Stroke, Acute Ischemic
| Sponsor | Trials |
|---|---|
| Xinqiao Hospital of Chongqing | 2 |
Sponsors with the most current trials registered for this condition.
Questions about Sorlandet Hospital HF trials
How many clinical trials does Sorlandet Hospital HF sponsor?
Sorlandet Hospital HF is the lead sponsor of 11 current trials on ClinicalTrials.gov in our Norway register, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.
Are Sorlandet Hospital HF trials recruiting?
Yes. 9 of its 11 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.